Company Overview and News

Baidu's AI Drive Hits Speed Bump With COO Departure

10h seekingalpha
The departure of Lu Qi from Baidu could deal a setback to some of the company’s less advanced and more ambitious efforts in artificial intelligence.

BIDU Stock: This Baidu Inc (ADR) Dip Is Another Long Trade Opportunity for Easy Profits | InvestorPlace

17h investorplace
Baidu Inc (ADR) (NASDAQ:BIDU) shares have been falling for the last two trading days on headlines. The company announced that its COO would be leaving and the stock also caught an analyst downgrade. This has been a proven winner, and I expect this malaise to pass. In a rising stock market, BIDU stock will be fine.

Center Of Gravity In Venture Cap Moving East

20h seekingalpha
Silicon Valley has long been the center of venture cap both in terms of investors and start-ups. However, more money is both being invested in Asian firms and funded by Asian firms. The bulk of this action is taking place in China where technology companies and investment firms are increasingly funding technologies both at home and abroad. At stake is whose technology will dominate the next generation of products such as artificial intelligence.

More Populism and More Inexperience: Global Week Ahead

20h zacks
The big headline out early on Monday is that Italy is likely to be run by a novice. Giuseppe Conte — a little-known 54-year-old professor who specializes in public administration law and has hardly any political experience — has emerged as the frontrunner to be prime minister for Italy’s nascent populist government, according to Italian media. Welcome to more populism, traders!

5 Top Stock Trades for Monday Morning | InvestorPlace

20h investorplace
With the exception of small caps, major U.S. stock indices took a breather this past week. That actually bodes well for the bull case, in my opinion. With that in mind, let’s get a look at our top stock trades for this week.

Monday’s Vital Data: Tesla Inc (TSLA), Chesapeake Energy Corporation (CHK) and Bidu Inc (BIDU) | InvestorPlace

20h investorplace
U.S. stock futures are surging higher this morning. Wall Street bulls are taking charge again after the U.S. and China called a trade truce that could lower America’s Chinese trade deficit.

China’s top Netflix-style app iQiyi plans on-demand cinemas in online-to-offline push

2018-05-21 scmp
China’s biggest online streaming app is going into the cinema business, with a twist. Instead of showing up at a certain time to view a certain movie, film buffs can now choose to book private on-demand cinemas by iQiyi Inc. to play their choice from the Beijing-based company’s library of titles.

Baidu Inc Takes a Hit on COO Departure

2018-05-19 investorplace
Baidu Inc (ADR) (NASDAQ:BIDU) stock took a hit today on news that Qi Lu will no longer be its COO.

Spotlight On Gambling Reset And Banking Bill

2018-05-19 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.

Venture Capital Deals Of The Week: Amazon And Blue Apron Competitor Gets $50M

2018-05-19 seekingalpha
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on Saturday mornings.

Baidu: Another Gift

2018-05-18 seekingalpha
Despite being a dominant player in the fast-growing internet space in China, Baidu (BIDU) consistently trades at a discount to American peers. The departure of a key executive and an analyst downgrade provide another gift to own this stock on a $25 dip and at levels from back in 2014.

Global X Launches AI and Big Data ETFs

2018-05-18 zacks
The artificial intelligence market, currently valued at $21.46 billion, is expected to reach $190.6 billion in 2025 as per MarketsandMarkets. In order to tap the exponential growth in the space, Global X launched Future Analytics ETF on May 15, making it the seventh fund in its Thematic-Technology lineup, which had AUM of $3.9 billion as of Apr 30 (read: First Trust Launches Another Robotics ETF).

Why Did Baidu (BIDU) Stock Drop Today?

2018-05-18 zacks
Shares of Chinese internet giant Baidu (BIDU - Free Report) were down more than 7.5% in early morning trading Friday after the company announced that Lu Qi, who oversaw the firm’s shift to artificial intelligence, is leaving his role as chief operating officer.

Why Baidu Inc. (ADR) Stock Is Down Over 5%

2018-05-18 marketrealist
Baidu Inc. (BIDU) is down over 5% in early trading following a press release this morning announcing that its Chief Operating Officer, Qi Lu, is stepping down due to “personal and family reasons.” Mr. Lu had a very short tenure with the company, as he was just hired back in January 2017, and he adds to the running list of executive departures at the Internet search giant.

China's Baidu says COO to step down

2018-05-18 reuters
BEIJING (Reuters) - China’s top search engine, Baidu Inc (BIDU.O), said on Friday its Chief Operating Officer Lu Qi will step down.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

16h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

16h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 056752108